DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20161707

Utility of fasting plasma glucose test as screening tool for gestational diabetes mellitus based on International Association of the Diabetes and Pregnancy Study Group criteria

Amita Sharma, Alpana Agrawal, Manisha Goel, Manisha Gupta

Abstract


Background: The International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria have recently been endorsed by various bodies for screening and diagnosing Gestational Diabetes (GDM). The present study was done to diagnose gestational diabetes (GDM) by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria in a North Indian Population and to evaluate the performance of fasting plasma glucose (FPG) in screening and diagnosis of GDM.

Methods: We conducted a prospective observational study on 417 pregnant women. The women were screened for GDM between 24 weeks and 28 weeks of gestation by 75-g oral glucose tolerance test (OGTT) and GDM diagnosed by the IADPSG criteria.

Results: The prevalence of GDM was 17.7% [95% Confidence interval (CI) 21.4 -14.1%] using the IADPSG criteria. Amongst the women diagnosed to have GDM, 64.9% had abnormal fasting plasma glucose (FPG). FPG cut-off value of 92 mg/dL identified 11.5% pregnant women with GDM. FPG cut-off value of 80 mg/dL ruled out GDM in 54.7% women. If 80 mg/dL were made the cut point to decide who should have the 75-g OGTT, then 56.8% (45.3 % with values <4.4 mmol/L plus 11.5 % with value >5.1 mmol/L) of pregnant women could avoid the 75-g OGTT with the probability that 1.9% of patients with GDM may be missed.

Conclusions: FPG at 24-28 weeks’ gestation could be used as a screening test to identify GDM patients. Women with an FPG between ≥ 80 mg/dL and ≤ 92 mg/dL would require a 75-g OGTT to diagnose GDM.


Keywords


GDM, IADPSG Criteria, FPG, Screening, Pregnancy

Full Text:

PDF

References


American Diabetic Association. Classification and diagnosis of diabetes mellitus. Diabetes Care. 2015;38 (Suppl 1):S8-16.

Damm P. Future risk of diabetes in mother and child after gestational diabetes mellitus. Int J Gynaecol Obstet. 2009;104(Suppl. 1):S25=6

Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477-86.

Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361:1339-48.

Metzger BE, Lowe LP,Dyer AR, et al; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991-2002

International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676-82.

Sacks DA, Hadden DR, Maresh M. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel–recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care. 2012;35:526-8.

Mohan V, Mahalakshmi MM, Bhavadharini B, Maheswari K, Kalaiyarasi G, Anjana RM, et al. Comparison of screening for gestational diabetes mellitus by oral glucose tolerance tests done in the non-fasting (random) and fasting states. Acta Diabetol. 2014;51:1007-13.

Agarwal MM, Dhatt GS, Shah SM. Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose. Diabetes Care. 2010;33:2018-20.

Donovan L, Hartling L, Muise M, Guthrie A, Vandermeer B, Dryden DM. Screening tests for gestational diabetes: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med.. 2013;159:115-22.

Seshiah V, Balaji V, Shah SN. Diagnosis of gestational diabetes mellitus in the community. J Assoc Physicians India. 2012;16:15-7.

Mahdavian M, Hivert MF, Baillargeon JP, Menard J, Ouellet A, Ardilouze JL. Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose: comment on Agarwal, Dhatt, and Shah. Diabetes Care. 2010;33:145.

Zhu W, Fan L, Yang H, Kong L, Su S, Wang Z, et al. Fasting plasma glucose at 24–28 weeks to screen for gestational diabetes mellitus: new evidence from China. Diabetes Care. 2013;36:2038-40.

Nayak PK, Mitra S, Sahoo JP, Daniel M, Mathew A, Padma A. Feto-maternal outcomes in women with and without gestational diabetes mellitus according to the international association of diabetes and pregnancy study groups (IADPSG) diagnostic criteria. Diabetes Metab Syndr. 2013;7:206-9.

Gopalakrishnan V, Singh R, Pradeep Y, Kapoor D, Rani AK, Pradhan S, et al. Evaluation of the prevalence of gestational diabetes mellitus in North Indians using the International Association of Diabetes and Pregnancy Study groups (IADPSG) criteria. J Postgrad Med. 2015;61:155‑8.

Mohan V, Usha S, Uma R. Screening for gestational diabetes in India: Where do we stand? J Postgrad Med. 2015;61:151-4.